The Emirates Times

Linkedin Twitter Facebook Tumblr

The Emirates Times

– Make It Happen
Enquire Now
Menu
  • HOME
  • INTERVIEW
  • UAE
  • GULF NEWS
    • Dubai
    • Jordan
    • Bahrain
    • Abu Dhabi
    • Saudi Arabia
    • Oman
  • BUSINESS
  • TECHNOLOGY
  • LIFESTYLE
  • EVENT
  • SUCCESS STORIES
  • METAVERSE

The Emirates Times

– Make It Happen
Menu
  • Home
  • Interview
  • UAE
  • Gulf News
    • BUSINESS
    • Dubai
    • Jordan
    • Saudi Arabia
    • Abu Dhabi
    • Bahrain
    • Oman
  • Technology
  • Lifestyle
    • Biography
    • EVENT
  • Metaverse
Home Gulf News

Cancer Surgery may be Replaced by a new Medication that “Melts” Tumors

June 20, 2024
in Gulf News, WORLD
0 0
0
Cancer Surgery may be Replaced by a new Medication that “Melts” Tumors

A team of British physicians has found a therapy that may eventually take the place of surgery, significantly improve the prognosis for bowel cancer patients, and dissolve tumors.

Physicians used the medication “Pembrolizumab,” which targets a particular protein and prevents it from being absorbed by immune cells, seeking out and eliminating cancer cells in clinical trials.

According to The Guardian, a clinical trial indicated that administering the medication before surgery rather than chemotherapy resulted in a notable rise in the number of patients who were deemed cancer-free.

The University of Glasgow, St. James’s Hospital, Southampton University Hospital, Christie NHS Foundation Trust, University College London, and University College London Hospital oversaw the study.

The Christie Foundation’s consultant clinical oncologist, Professor Mark Saunders, stated that the trial’s outcomes were encouraging and that preoperative immunotherapy “may become a radical change in the treatment of patients with this type of cancer.” Not only is the result superior, but it also spares patients from the more side-effect-prone conventional chemotherapy.

The researchers observed that roughly 15% of the individuals under study had a unique genetic composition while studying 32 patients with second- or third-stage bowel cancer across five hospitals in the United Kingdom.

The patients were observed over time after receiving pembrolizumab, commonly referred to as Keytruda, for nine weeks before surgery as an alternative to chemotherapy and surgery.

Also Read:

For Hours, Fog Envelops Some of the UAE’s Coastal Regions 

A New UAE Aid Ship Leaves Cyprus For the Gaza Strip

ShareTweetSend
Next Post
Home

Those Looking to Make the UAE their Second Home can Stay Longer with Eight Different Types of Visas

No Result
View All Result

Latest Posts

buy safety shoes in UAE
UAE

Protective footwear for the UAE oil and gas sector: anti-static and oil resistant solutions

by Editor
August 1, 2025
0

The UAE oil and gas industry is a challenging environment, with high risks and a work environment where a mistake...

Read more
Founder and CEO of The Holistic Alternatives

Empowering Healing Through Knowledge: A Conversation with the Founder of The Holistic Alternatives

July 30, 2025
Ring Selection

Finding ‘The One’: A Thoughtful Approach to Ring Selection

July 24, 2025
finencialproces

ICU’s Involvement in Certain Financial Processes and Their Implications

July 21, 2025
Dr Narimane Had-Hamou, Founder

Transforming Arab Higher Education: An Exclusive Conversation with Dr Narimane Had-Hamou, Founder & CEO of CLICKS

July 22, 2025

Follow Us

The Emirates Times

– Make It Happen
The Emirates Times is an English Language Internet media with a significant focus on business, technology, news, entrepreneurship, leadership, innovation, prominent business personalities, and many more, majorly in the GCC region. Further, the company publishes interviews, news, business content, press releases, etc. This platform also publishes about real estate, sports, metaverse, business ideas, and more.
Linkedin Twitter Facebook Tumblr

Important links

  • HOME
  • INTERVIEW
  • UAE
  • GULF NEWS
  • TECHNOLOGY
  • LIFESTYLE
  • METAVERSE

Contact Us

  • sales@theemiratestimes.com
  • +91-70-6556-6556

© 2024 theemiratestimes